DOPE-GA

• UNSPSC Description:

  DOPE-GA can be used for formulation of liposome, and used in the research of drug delivery[1].

• Target Antigen:

  Liposome

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/dope-ga.html

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  OC(CCCC(NCCOP(OC[C@@H](COC(CCCCCCC/C=C\CCCCCCCC)=O)OC(CCCCCCC/C=C\CCCCCCCC)=O)(O)=O)=O)=O

• Molecular Weight:

  858.13

• References & Citations:

  [1]Cuvillier O, et al. Liposomal ET-18-OCH(3) induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood. 1999 Nov 15;94(10):3583-92. |[2]Perkins WR, et al. Novel therapeutic nano-particles (lipocores): trapping poorly water soluble compounds. Int J Pharm. 2000 Apr 25;200(1):27-39.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  228706-30-7